Biblio

Author Title [ Type

] Year

Filters: Author is Ma, Wei [Clear All Filters]

Journal Article

Ma W, Wei X, Gu H, Li H, Guan K, Liu D, Chen L, Cao S, An D, Zhang H, et al. Sensory neuron differentiation potential of in utero mesenchymal stem cell transplantation in rat fetuses with spina bifida aperta. Birth Defects Res A Clin Mol Teratol. 2015.

Zhang R, Dong M, Tu J, Li F, Deng Q, Xu J, He X, Ding J, Xia J, Sheng D, et al. PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway. Signal Transduct Target Ther. 2023;8(1):97.

Ma L, Wei X, Ma W, Liu Y, Wang Y, He Y, Jia S, Wang Y, Luo W, Liu D, et al. Neural Stem Cell-Derived Exosomal Netrin1 Contributes to Neuron Differentiation of Mesenchymal Stem Cells in Therapy of Spinal Bifida Aperta. Stem Cells Transl Med. 2022.

Ma W, Yang J-W, Bin Wang X-, Luo T, Zhou L, Lagares A, Li H, Liang Z, Liu K-P, Zang C-H, et al. Negative regulation by proBDNF signaling of peripheral neurogenesis in the sensory ganglia of adult rats. Biomed Pharmacother. 2021;144:112273.

Ma W, Zhang L, Chen W, Chang Z, Tu J, Qin Y, Yao Y, Dong M, Ding J, Li S, et al. Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1. Protein Cell. 2024.

Ma W, Wei X, Gu H, Liu D, Luo W, Cao S, Jia S, He Y, Chen L, Bai Y, et al. Intra-amniotic transplantation of brain-derived neurotrophic factor-modified mesenchymal stem cells treatment for rat fetuses with spina bifida aperta. Stem Cell Res Ther. 2022;13(1):413.

Wei X, Cao S, Ma W, Zhang C, Gu H, Liu D, Luo W, Bai Y, Wang W, Yuan Z. Intra-Amniotic Delivery of CRMP4 siRNA Improves Mesenchymal Stem Cell Therapy in a Rat Spina Bifida Model. Mol Ther Nucleic Acids. 2020;20:502-517.

Li G, Guan Y, Gu Y, Guo M, Ma W, Shao Q, Liu J, Ji X. Intermittent hypoxic conditioning restores neurological dysfunction of mice induced by long-term hypoxia. CNS Neurosci Ther. 2022.

Lu Y, Zhang C, Li Q, Mao J, Ma W, Yu X, Hou Z, Li L. [Inhibitory effect of salinomycin on human breast cancer cells MDA-MB-231 proliferation through Hedgehog signaling pathway]. Zhonghua Bing Li Xue Za Zhi. 2015;44(6):395-398.

Zhou L, Sheng D, Wang D, Ma W, Deng Q, Deng L, Liu S. Identification of cancer-type specific expression patterns for active aldehyde dehydrogenase (ALDH) isoforms in ALDEFLUOR assay. Cell Biol Toxicol. 2018.

Zheng Z, Guo Z, Zhong F, Wang B, Liu L, Ma W, Yu C-Y, Wei H. A dual crosslinked hydrogel-mediated integrated peptides and BMSC therapy for myocardial regeneration. J Control Release. 2022.

Xue S, Sun H-P, Huang X-B, Chen X, Wang T, Ma W, Tian Y, Pan Z-L, Li L-H, Zhang L, et al. Characteristics and literature review of ETV6::ABL1 fusion gene-positive acute myeloid leukemia. Int J Hematol. 2024.

Sheng D, Ma W, Zhang R, Zhou L, Deng Q, Tu J, Chen W, Zhang F, Gao N, Dong M, et al. Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarization. J Immunother Cancer. 2022;10(5).

Chen W, Qin Y, Wang D, Zhou L, Liu Y, Chen S, Yin L, Xiao Y, Yao X-H, Yang X, et al. CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer. PLoS Biol. 2018;16(7):e2005869.

Ma C, Lang H, Chen Y, Yang L, Wang C, Han L, Chen X, Ma W. Azacitidine combined with venetoclax alleviates AML-MR with TP53 mutation in SDS: a case report and literature review. Anticancer Drugs. 2024.

Cao X-Y, Chen J-Q, Wang H, Ma W, Liu W-W, Zhang F-F, Xue S, Dong L, Liu T, Zhao X-Z, et al. Addition of venetoclax to myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in high-risk AML. Ann Med. 2023;55(1):388-400.